Genomic characterization of HNSCC has recently been reported, and amplification of receptor tyrosine kinases, including EGFR and ERBB2, was commonly identified in HPV‐negative HNSCC.12 This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.